Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initiation of statin therapy in patients with diabetes mellitus: a target trial emulation study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Factors affecting human papillomavirus vaccine acceptance among parents of Primary 4 to 6 boys and girls in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Dynamics of childhood obesity in Hong Kong throughout the COVID-19 pandemic before and after the school closures: a 3-year longitudinal study.

Public health·2023
Same author

Elevated risk of multimorbidity post-COVID-19 infection: protective effect of vaccination.

QJM : monthly journal of the Association of Physicians·2023
Same author

Descriptive analysis of poisoning cases involving attention deficit hyperactivity disorder medications in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2023
Same author

Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic.

European child & adolescent psychiatry·2023

Related Experiment Video

Updated: Jun 29, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Minimising medication errors in children.

I C K Wong1, L Y L Wong, N E Cranswick

  • 1Centre for Paediatric Pharmacy Research, The School of Pharmacy, University of London and Taskforce in Europe for Drug Development for the Young, London, UK. ian.wong@pharmacy.ac.uk

Archives of Disease in Childhood
|October 3, 2008
PubMed
Summary

Paediatric medication errors pose significant risks due to formulation issues, communication breakdowns, and calculation mistakes. Strategies like electronic prescribing and pharmacist involvement can reduce these critical errors in children.

Related Experiment Videos

Last Updated: Jun 29, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Area of Science:

  • Pediatric Healthcare
  • Medication Safety
  • Clinical Risk Management

Background:

  • Medical errors, particularly medication errors, represent a significant challenge in healthcare systems globally.
  • While research has largely focused on adult populations, recent evidence indicates that medication errors are also a substantial issue in pediatric care.
  • These errors incur direct financial costs, personal tolls on patients and staff, and erode public trust in healthcare.

Purpose of the Study:

  • To review the key factors contributing to medication errors in pediatric patients.
  • To discuss effective risk reduction strategies for minimizing these errors.
  • To highlight the importance of a multi-faceted approach involving technology, communication, and best practices.

Main Methods:

  • Literature review of studies on paediatric medication errors.
  • Analysis of contributing factors, including formulation availability, communication, dose calculation, and clinical practices.
  • Examination of risk mitigation strategies, such as electronic prescribing and computerized physician order entry (CPOE).

Main Results:

  • Identified key contributors to paediatric medication errors: lack of appropriate pediatric formulations, interprofessional communication challenges, dose calculation errors, and suboptimal clinical practices.
  • Highlighted the potential of electronic prescribing and CPOE systems to significantly decrease medication errors.
  • Emphasized the role of pharmacist monitoring and improved communication in enhancing safety.

Conclusions:

  • Paediatric medication errors are a serious concern with multifactorial causes.
  • Implementing technological solutions like CPOE and electronic prescribing, alongside enhanced communication and pharmacist oversight, is crucial for reducing these errors.
  • Fostering environments that promote best practices is essential for improving medication safety in children.